 | AnaptysBio, Inc. | |||
| NMS : ANAB || Location: United States | ||||
$19.87+0.04 (+0.2%) |
0.29 M | 19.08 - 20.66 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 4.304 M |
| March 15, 2024 | 4.136 M |
| Feb. 29, 2024 | 4.201 M |
| Feb. 15, 2024 | 4.506 M |
| Jan. 31, 2024 | 5.115 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -1.63 | -1.59 | 2.65% |
| 09/30/2023 | -1.83 | -1.41 | 22.95% |
| 06/30/2023 | -1.73 | -1.50 | 13.36% |
| 03/31/2023 | -1.07 | -1.58 | -47.80% |
| 12/31/2022 | -0.98 | -0.93 | 4.74% |
ANAB Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 26.763M | Shares Float | 14.734M |
| Short Float | 4.304M | Market Cap | 530.71M |
| Institution ownership | 0.00% | Insider ownership | 0.400% |
| Earnings Date | 05/08/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -6.08 | Forward EPS | -5.96 |